BLGO - BioLargo, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue281.106127.582111.547
Cost of Revenue105.87762.06755.999
Gross Profit175.22965.51555.548
Operating Expenses
Research Development1,381.956684.554642.923
Selling General and Administrative3,714.3983,551.5222,793.119
Non Recurring---
Others13.73610.9210.92
Total Operating Expenses---
Operating Income or Loss-4,934.861-4,181.481-3,391.414
Income from Continuing Operations
Total Other Income/Expenses Net-10.3799.12299.122
Earnings Before Interest and Taxes-4,945.231-4,082.359-3,391.414
Interest Expense3,129.104994.671348.153
Income Before Tax-8,074.335-5,077.03-3,739.567
Income Tax Expense---
Minority Interest554.969789.57360.627
Net Income From Continuing Ops-7,839.731-5,055.976-3,692.116
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,839.731-5,055.976-3,692.116
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,839.731-5,055.976-3,692.116